Filing Flows › Core Laboratories (CLB) › Guidance history
Core Laboratories (CLB) guidance history: what it guided and what it reported
Core Laboratories gave guidance in 3 earnings releases on file since Apr 29, 2026. Its releases raised guidance twice and lowered it 0 times.
Adjusted revenue
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q3 2026 | $84.0M (Jul 29, 2026) | — | — | — |
| Q2 2026 | $82.5M (Apr 29, 2026) | — | — | — |
Adjusted operating margin
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | 10.0% (Oct 28, 2026) | — | to be reported | — |
| Q3 2026 | 10.0% (Jul 29, 2026) | — | — | — |
| Q2 2026 | 7.0% (Apr 29, 2026) | — | — | — |
Adjusted operating income
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | $5.1M–$8.3M (Oct 28, 2026) | — | to be reported | — |
| Q3 2026 | $5.5M–$7.9M (Jul 29, 2026) | — | — | — |
| Q2 2026 | $3.5M–$5.4M (Apr 29, 2026) | — | — | — |
Adjusted tax rate
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | 25.0% (Oct 28, 2026) | — | to be reported | — |
| Q3 2026 | 25.0% (Jul 29, 2026) | — | — | — |
| Q2 2026 | 25.0% (Apr 29, 2026) | — | — | — |
Adjusted EPS
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | $0.12–$0.20 (Oct 28, 2026) | — | to be reported | — |
| Q3 2026 | $0.12–$0.20 (Jul 29, 2026) | — | — | — |
| Q2 2026 | $0.06–$0.12 (Apr 29, 2026) | — | — | — |
The latest quarter
Core Laboratories, Q3 2026: revenue $132M (-2% year over year), operating margin 9.1%, net earnings $5.4M, operating cash flow $5.0M. The chart follows the revenue to costs, profit and cash.
Questions
Does Core Laboratories beat its guidance?
Core Laboratories gave guidance in 3 earnings releases on file since Apr 29, 2026. Its releases raised guidance twice and lowered it 0 times.
How often does Core Laboratories raise guidance?
Its earnings releases raised guidance twice and lowered it 0 times since Apr 29, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.